SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : Canadian Political Free-for-All

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: russet9/21/2025 5:48:23 PM
1 Recommendation

Recommended By
longz

   of 37066
 
This explains why the Liberals legalized cannabis.

More studies definitely needed.

High-THC Cannabis Products Linked to Immediate Psychosis and Addiction
The link is based on a new review of 99 studies involving more than 220,000 people.


George Citroner

9/19/2025|Updated: 9/21/2025

As marijuana legalization spreads nationwide and young Americans increasingly view cannabis as harmless, new research reveals a paradox: Modern products such as vapes, dabs, and concentrates with high levels of tetrahydrocannabinol or THC, the main psychoactive ingredient, are triggering serious mental health problems at rates far higher than the marijuana of previous generations.

Using cannabis products with high levels of THC is linked with increased risk for psychosis or schizophrenia, especially within 12 hours after use, a new review of 99 studies found.

Modern Cannabis Packs Unprecedented Punch

Using highly concentrated THC products was consistently linked to mental health risks such as psychosis, schizophrenia, and addiction.
The review, recently published in the Annals of Internal Medicine, examined studies conducted between 1977 and 2023, finding that high-THC products showed consistent associations with increased risks of psychosis and schizophrenia. The study involved more than 221,000 participants from 15 countries.
From the 1960s to the 1980s, typical THC levels in cannabis flower increased from 2 to 4 percent to the current average of 20 percent.

Modern vaping devices can deliver THC concentrations ranging from 70 to 90 percent, significantly exceeding previous levels and raising concerns about the associated health risks, researchers noted.

Some of the studies reviewed found that THC was beneficial in treating anxiety and depression, especially in people with cancer and other neurological conditions. However, for recreational use in healthy people, the opposite effect was seen.

Related Stories

Cannabis Users Face Up to 5-Fold Higher Risk of Benign Mouth Tumors

Cannabis Use Disorder Associated With Higher Colon Cancer Mortality Risks

For people who use cannabis for recreational reasons, 53 percent of the study linked high-THC cannabis to increased anxiety, and 41 percent associated it with depression.

The review also highlights that people who frequently use high-potency products are more likely to develop cannabis use disorder—which “carries its own burden on mood, motivation, and daily functioning,” Dr. Nona Kocher, a board-certified psychiatrist at Quintessence Psychiatry in Miami, who was not involved in the study, told The Epoch Times.

“Evidence also suggests that tolerance and withdrawal symptoms are more pronounced with concentrates, both of which feed into the cycle of dependence,” Kocher added.

Effects of High THC Concentrations

THC is the primary psychoactive ingredient of cannabis and can biologically act on endocannabinoid receptors in the nervous system. Activation of these receptors can disrupt normal neural signaling, especially neurotransmitters crucial for maintaining mood, cognition, and perception.
These disruptions may contribute to psychotic symptoms. For example, dopamine is a key neurotransmitter that regulates mood and perception. If the dopaminergic system gets disrupted and too much dopamine gets released, it could put people at risk of hallucinations.
Additionally, acute intoxication with high doses of THC can also introduce hallucinations, paranoia, and other signs that may mimic schizophrenia.

Limited Therapeutic Benefits, Clear Risks

Despite growing claims about marijuana’s medical benefits, the review found little evidence supporting high-THC products for mental health treatment. Dr. Jonathan M. Samet, the study’s corresponding author and professor of epidemiology at Colorado School of Public Health, told The Epoch Times that no therapeutic studies found THC had positive effects for those living with psychosis or schizophrenia.
While some studies suggested potential benefits for anxiety and depression, the evidence remained “weak and inconsistent,” according to Samet.

For studies suggesting potential THC benefits, less than half showed that high-THC cannabis might help with anxiety. Others found unfavorable effects—with 24 percent of studies showing increased anxiety and 30 percent showing increased depression.

The research carries significant implications for the growing movement to legalize recreational marijuana.

However, the researchers acknowledged important limitations in current evidence.

The reviewed studies didn’t capture how people consumed THC—whether smoked, vaped, or eaten. The studies also used inconsistent measurement tools and underrepresented pregnant women and adolescents among participants.

“Given the growing number of states with recreational marijuana use now legalized and the increasing THC concentrations,” Samet said, “We need to have better information available to answer reasonable questions [about the risk] with more certainty.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext